Can a single dose of tocilizumab clear the way for a second kidney transplant?
NCT ID NCT04779957
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 pilot study tested whether a single dose of tocilizumab, given before or after removing a failed kidney transplant, is safe and can reduce harmful antibodies that make a second transplant difficult. The study involved 18 adults who needed their kidney graft removed and hoped for another transplant. The main focus was on serious infections, but researchers also looked at overall complications and antibody levels one year later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tocilizumab
- What this could lead to
- If it works, this could help people who lose a kidney transplant have a better chance of getting a second one by reducing immune system barriers.
- What could go wrong
- This is a small, early-phase pilot study with only 18 participants, so results may not apply to everyone. The drug may also increase the risk of serious infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT FAILURE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Toulouse
Toulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may spot hidden kidney transplant rejection
- A drug given to organ donors may help kidneys work faster after transplant
- Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test
- Blood test clues could make antifungal dosing safer for transplant patients
- New Two-Step therapy aims to stop chronic kidney transplant rejection
- Smartphone app and booklet could help kidney transplant patients stick to medications